• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Eclinso partners with XClinical

Eclinso partners with XClinical

March 8, 2012
CenterWatch Staff

Eclinso, a provider of clinical information technology, consulting and business process outsourcing services, has entered into a strategic partnership agreement with XClinical, an eClinical technology solutions company offering its CDISC-certified electronic data capture (EDC) and data management (DM) system MARVIN and related tools, such as STUDY COMPOSER and TABULATOR.

The combined solutions—Eclinso’s Trialforce Platform and XClinical's EDC system MARVIN—offer flexibility and adaptability to sponsors and CROs for capturing and managing their clinical data. Trialforce, a managed application platform, is fully compliant to industry standards 21CFR11, CDISC, HIPAA, W3C and GCP, with support for over 50 languages (including double byte languages such as Chinese). Trialforce is a cloud-based platform with no local software or hardware to support. Based on a Software as a Service (SaaS) pricing model, there are minimal upfront costs, lowering the initial licensing fees traditionally associated with EDC and data management solutions.

MARVIN can be used across all types of therapeutic areas; adapting to any type of clinical trial including phase I-IV interventional studies, medical device trials, observational studies, registry trials, prevention studies, genetic investigations, diagnostic trials and outcomes research. MARVIN is built on CDISC standards that enable pharmaceutical companies, CROs and MedTech companies to increase clinical trial efficiency. STUDY COMPOSER, the EDC design tool, offers an intuitive graphical point-and-click interface for defining a trial and creating relevant metadata. Study Composer automatically generates the eCRF design, accelerating the clinical trial process.

Combined with Trialforce, MARVIN offers visibility, exception management and analysis of information from clinical trials, enabling trial sponsors and managers to make critical decisions during and throughout a trial. Integration and interoperability through other Trialforce solutions, such as IVR and ePRO, can be provided easily and seamlessly. 

"XClinical shares our philosophy of providing innovative solutions based on industry standards, which enables interoperability within our Trialforce platform,” said Frank Pijpers, CEO of Eclinso. “The convergence of cloud-based solutions such as Trialforce with MARVIN will significantly improve clinical trial efficiency while reducing costs."  

Eclinso has offices in Switzerland,California and New Jersey. XClinical has operations in Germany, France and Massachusetts.

 

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing